Clinical Trial Update: Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating a combination of pegylated interferon and ribavirin in chronic hepatitis C patients who relapsed after prior therapy has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Göteborg University | Conditions: Chronic Hepatitis C | Phase 4 | Status: TERMINATED